These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1646586)

  • 1. Acyclovir to prevent cytomegalovirus infection after renal transplantation.
    Wong T; Toupance O; Chanard J
    Ann Intern Med; 1991 Jul; 115(1):68. PubMed ID: 1646586
    [No Abstract]   [Full Text] [Related]  

  • 2. Acyclovir to prevent cytomegalovirus infection in renal-graft recipients.
    Grundy JE; Griffiths PD
    N Engl J Med; 1989 Nov; 321(18):1268-9. PubMed ID: 2552315
    [No Abstract]   [Full Text] [Related]  

  • 3. Ganciclovir for cytomegalovirus infection in renal transplant recipients.
    Lancet; 1989 Jan; 1(8631):216-7. PubMed ID: 2563118
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.
    Kuypers DR; Vanrenterghem YF
    Nephrol Dial Transplant; 1999 Oct; 14(10):2304-8. PubMed ID: 10528649
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits.
    Bertoni E; Rosati A; Zanazzi M; Moscarelli L; Di Maria L; Piperno R; Orsi A; Parri F; Dedola G; Salvadori M
    Transplant Proc; 1998 Aug; 30(5):2094. PubMed ID: 9723402
    [No Abstract]   [Full Text] [Related]  

  • 6. The renal safety of high doses of valacyclovir for prevention of cytomegalovirus infection after renal transplantation.
    Le Meur Y; Mons S; Moesch C; Leroux-Robert C
    Nephrol Dial Transplant; 2000 Mar; 15(3):442. PubMed ID: 10692544
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.
    Balfour HH; Chace BA; Stapleton JT; Simmons RL; Fryd DS
    N Engl J Med; 1989 May; 320(21):1381-7. PubMed ID: 2541335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient.
    Uber L; Cofer J; Baliga P; Rajagopalan PR
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):42-3. PubMed ID: 7482818
    [No Abstract]   [Full Text] [Related]  

  • 9. Acyclovir for cytomegalovirus infection.
    Selby P; Powles R; Stolle K; Stern H
    Br Med J (Clin Res Ed); 1984 Jul; 289(6439):253. PubMed ID: 6331564
    [No Abstract]   [Full Text] [Related]  

  • 10. Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients.
    Carrieri G; Jordan ML; Shapiro R; Scantlebury VP; Vivas C; Kusne S; Magnone M; McCauley J; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):961-3. PubMed ID: 7879246
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
    Pouteil-Noble C; Megas F; Chapuis F; Bosshard S; Colin C; Hadj-Aissa A; Pozet N; Martin X; Lefrançois N; Garnier JL; Aymard M; Touraine JL
    Transplant Proc; 1996 Oct; 28(5):2811. PubMed ID: 8908072
    [No Abstract]   [Full Text] [Related]  

  • 12. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
    Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
    N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis.
    Kizilisik TA; Preiksaitis JK; Kneteman NM
    Transplant Proc; 1993 Jun; 25(3):2282-3. PubMed ID: 8390739
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir.
    Eisenmann D; Knipp H; Laube H; Stegmann T
    Transplant Proc; 1990 Oct; 22(5):2322-3. PubMed ID: 2171169
    [No Abstract]   [Full Text] [Related]  

  • 15. Valacyclovir to prevent cytomegalovirus disease after renal transplantation.
    Shapiro ME; Abrams JM
    N Engl J Med; 1999 Sep; 341(12):921. PubMed ID: 10498468
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir.
    Zhang P; Wang W; Zhang L; Li SF; Guan LB; Dong LQ; Zhou S; Yu P
    Acta Virol; 2013; 57(3):375-7. PubMed ID: 24020766
    [No Abstract]   [Full Text] [Related]  

  • 17. Acyclovir in cytomegalovirus infection 3 1/2 years after renal transplantation. An unusual case and dramatic response.
    Barnett PS; Meyers AM; Schoub BD; Johnson S; Botha JR
    S Afr Med J; 1984 Oct; 66(17):635-7. PubMed ID: 6093274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of cytomegalovirus infection in renal transplantation.
    Ostermann M; MacPhee I; Chang R
    Nephrol Dial Transplant; 2001 Nov; 16(11):2276-9. PubMed ID: 11682689
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with oral acyclovir.
    Balfour HH; Fletcher CV; Dunn D
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):17-9. PubMed ID: 1647558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.